|
|||||
|
|
Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms |
|
| Institution: | 1. Division of Hematology and Oncology, Department of Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan;2. College of Medicine, Chang Gung University, Tao-Yuan, Taiwan |
| Abstract: | |
| Keywords: | Ropeginterferon alpha-2b Myeloproliferative neoplasm hepcidin Polycythemia vera Molecular response |
| 本文献已被 ScienceDirect 等数据库收录！ | |